Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)
作者
Paweł Kawalec
出处
期刊:Value in Health [Elsevier BV] 日期:2016-10-31卷期号:19 (7): A708-A708被引量:1